Controlled TPCA-1 delivery engineers a pro-tenogenic niche to initiate tendon regeneration by targeting IKKβ/NF-κB signaling.
Chen J, Sheng R, Mo Q, Backman LJ, Lu Z, Long Q, Chen Z, Cao Z, Zhang Y, Liu C, Zheng H, Qi Y, Cao M, Rui Y, Zhang W.
Chen J, et al. Among authors: sheng r.
Bioact Mater. 2024 Oct 23;44:319-338. doi: 10.1016/j.bioactmat.2024.10.016. eCollection 2025 Feb.
Bioact Mater. 2024.
PMID: 39512422
Free PMC article.